Skip to content
o2h discovery logo

o2h discovery website

o2h discovery – seeding new ideas in life science, tech and green …

o2h discovery logo
  • about
    • company overview
    • team
    • ESG
    • o2h community
  • how we deliver
  • news
  • events
    • exhibiting/attending events
    • o2h Innovation Conference
    • Bootcamps
    • AIM squad
    • Cambridge Wide Open Day
    • Cambridge TechBIO Caucus
    • Biotech Bikers
    • o2h Chaitime Webinar
  • culture & careers
  • CITCTM
  • o2h group
  • integrated(drug discovery)
    • o2h Plug-in Biotech
    • Target Identification and Validation
    • Hit Identification
    • Hit to Lead
    • Lead Optimization
    • Targeted protein degradation
    • Fragment-based Drug Discovery
    • Knowledge-based drug design and SAR
    • Early assessment of in vitro ADMET and PK
  • chemistry
    • medicinal chemistry
    • synthetic chemistry
    • peptide synthesis service
    • PROTAC Services
    • Lipid Nanoparticles (LNPs)
    • analytical chemistry
    • ADCs – linker/payloads
    • o2h kickstarter, Global
    • o2h Kickstarter, Innovate America
    • o2h Platinum Partner
    • o2h fast pharma 18
  • biology
    • target engagement and validation
      • PROTAC
      • NanoBRET/NanoBiT
      • NaLTSA
      • CRISPR/Cas9
      • siRNA/shRNA
      • Undruggable targets and genetic benchmarking
    • Assay biology
      • Biophysical
      • Biochemical
      • Cellular
      • Gene expression
      • Drug-Drug interactions and synthetic lethality
      • Biomarker assessment
      • Site-directed mutagenesis & binding studies
    • Drug Screening
      • Iterative screening
      • Primary, orthogonal and selectivity
      • Fragment-based screening
      • Phenotypic screening
    • Biology Insights
      • Biochemistry
      • RNA Binding Small Molecule
      • High-Content Imaging
      • Immuno-Oncology Therapeutics
      • Psychedelics
      • Read more…
    • Biology Match Funding
  • DMPK
    • in-vitro ADME
    • in-vivo Pharmacokinetics (PK)
  • scale-up
    • kilo-lab
    • non-GMP
    • GMP [partnership]
  • catalog
  • contact
catalog-logo
e:catalog@o2h.com o2h discovery
compare-icon 0
cart-icon 0
Get quote
catalog-logo
  • m:
  • e:catalog@o2h.com
  • o2h discovery
  • compare-icon 0
  • cart-icon 0
  • Get quote

Added successfully to RFQ list

Added successfully to compare list

meet the team

filter:

Sunil

Sunil Shah

CEO - o2h Ventures and Co-Founder - o2h discovery

Sunil's Biography

Read more

Sunil Shah

CEO - o2h Ventures and Co-Founder - o2h discovery

A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University


Connect on linkedin

prashant shah

Prashant Shah

CEO - o2h discovery and Co-Founder - o2h group

Prashant's Biography

Read more

Prashant Shah

CEO - o2h discovery and Co-Founder - o2h group

Prashant is a serial entrepreneur in life sciences and tech in which one of those companies was acquired by a public company. He is currently active in seed investing (a portfolio of ~50 companies), product/IP development, services, and building lab/office infrastructure. The early career was with the Strategy group at Accenture. He has a BEng, an MSc, in which he worked on the Human Genome Program at the Sanger Centre, and an MPhil in Management from the Judge Institute. Prashant is also a General Partner in the o2h SEIS/EIS Human Health Funds.


Connect on linkedin

Andy Morley

Andy Morley

Chief Scientific Officer

Andy's Biography

Read more

Andy Morley

Chief Scientific Officer

Andy is the Chief Scientific Officer (CSO) at o2h Discovery. He also leads scientific evaluations for investments and provides strategic scientific support across key portfolio projects for o2h Ventures. With over 25 years of experience as a Medicinal Chemist, Andy has worked with major pharmaceutical companies, including Sanofi-Aventis and AstraZeneca. He has contributed across all phases of drug discovery and has played a key role in advancing five candidates into clinical trials. Andy is also the author and inventor of over 55 publications and patents.


Connect on linkedin

Nilesh Dagia

Nilesh Dagia

Chief Special Projects Officer

Nilesh's Biography

Read more

Nilesh Dagia

Chief Special Projects Officer

Nilesh leads the global operations of o2h group covering a wide range of innovation led investment, life-science and technology businesses. He is also overseeing the development and execution of the new o2h discovery Shirish Research Centre in Ahmedabad, India. Prior to joining o2h group, Nilesh worked with Piramal Group in various capacities including as an Alliance Manager for a risk-share oncology-based collaboration with a US Big Pharma and has also worked as the Head of Biology in Piramal Discovery solutions. Nilesh obtained his Ph.D. from Ohio University and completed a post-doc in Immunology, Stem Cells and Regenerative Medicine at Harvard Medical School. He is the author and inventor of >30 life science patents and publications. He received the Young Scientist of India award from OPPI in 2010.


Connect on linkedin

David Davies - o2h

David Davies

Head of Medicinal Chemistry

David's Biography

Read more

David Davies

Head of Medicinal Chemistry

David Davies has 25 years of experience in medicinal chemistry within the pharmaceutical industry with a focus on the antibacterial area (clavulanates, penicillinates, pseudomonates and bacterial topoisomerase inhibitors). He previously worked at GSK and currently holds a part-time academic position at University College London (UCL). He served as the Head of Medicinal Chemistry at Antabio for nearly a decade, specialising in antibacterial research, and has extensive experience managing chemistry projects in multiple countries including France, UK, India and China. He is the inventor of 40 patents and has authored 37 publications.


Connect on linkedin

Claudio Dagostin

Claudio Dagostin

Vice President - Business Development (UK & Europe)

Claudio's Biography

Read more

Claudio Dagostin

Vice President - Business Development (UK & Europe)

Claudio obtained his PhD in Chemistry (Mechanisms of Organic Reactions) from the University of Rome in 2000. He went for a post-doc at Imperial College London where he worked on Alzheimer’s disease chemical probes. In 2004, he started working in several companies in the Cambridge biotech cluster where he deepened his knowledge in Medicinal Chemistry and in Fragment Based Drug Design. In 2012, he went back to academia at Cambridge University where he investigated challenging drug targets such as protein-protein interactions. He also co-founded the Entrepreneurial Postdocs of Cambridge (EPOC) society in 2015 to support postdocs in their pursuit of entrepreneurial careers. In 2017, joined Capital Cell with a role in Business Development, then Abzena in Cambridge and finally o2h in January 2021.


Connect on linkedin

cat stace

Catherine Stace (PhD MBA)

Vice President - Business Development (East Coast USA) & Strategic Relationship

Cat's Biography

Read more

Catherine Stace (PhD MBA)

Vice President - Business Development (East Coast USA) & Strategic Relationship

Catherine holds over 18 years of post-doctoral experience in therapeutic discovery, with strategic roles in biotechnology, consultancy, and CRO organizations. She has contributed to small molecule therapeutics, peptides, health tech, and engineering. She started her career at Isogenica and Bicycle Therapeutics, establishing therapeutic platforms and discovery programs. She has also consulted for various biotech and health tech start-ups to develop platform technologies at the intersection of biology and engineering. Before joining o2h, she was EVP of Business Development at Domainex, collaborating with companies in the UK, USA, and Europe.

She has completed an MSc in Biochemistry from Nottingham, a PhD in Cell Biology from Cambridge, and an MBA from the Open University.


Connect on linkedin

Tejas Upadhyay

Tejas Upadhyay

Vice President - Business Development (USA)

Tejas's Biography

Read more

Tejas Upadhyay

Vice President - Business Development (USA)

Tejas holds a master’s degree from Gujarat University, earned his PhD in India, and gained valuable post-doctoral experience at the University of Glasgow in the United Kingdom. His professional journey commenced at Alembic, and he has since contributed his expertise to several contract research organisations, including Evotec, o2h, and Piramal. Currently, he oversees all projects in the USA region. With a background in chemistry, he boasts over two decades of experience in the field of preclinical drug discovery.


Connect on linkedin

Gayathri Sadasivam

Gayathri Sadasivam

Vice President - Biology

Gayathri's Biography

Read more

Gayathri Sadasivam

Vice President - Biology

Gayathri leads the biology capabilities in Ahmedabad, India and Cambridge, UK. She also significantly contributes to the business development with the o2h customers world-wide, understanding the market requirements, contributing to technology transfer and investment evaluations. Prior to this, she has worked for more than 2 decades in different therapeutic areas in both industry and academia. She has led multiple programs in drug discovery projects through lead optimization to candidate selection and further development to late stage clinical trials. She has worked in a multi-disciplinary environment, leading chemical biology efforts creating chemical tools that modulate novel class of “undruggable” targets. Gayathri has a Ph.D. in Neuroscience from the Brain Research Institute, Zurich, Switzerland.


Connect on linkedin

Hemal Soni

Hemal Soni

Vice President - Chemistry

Hemal's Biography

Read more

Hemal Soni

Vice President - Chemistry

Hemal has comprehensive experience in leading & guiding multi-FTE synthetic chemistry research and development collaborations which are in support of the fast-paced drug discovery programs. At o2h discovery, he oversees the progress and troubleshooting of all the ongoing projects and helps with evaluation as well as kick start of new programs.

 

Hemal obtained his Ph.D. in organic chemistry from Kadi Sarva University, Gujarat. He has >17 years of industrial experience. Prior to joining o2h discovery, Hemal worked with Piramal Discovery Solutions (PDS) for 4 years during which he led the largest project covering 42 FTEs for a UK-based collaborator. He has worked with clients all around the world including UK, USA, Japan, Australia, Singapore and more.


Connect on linkedin

Dharmesh Bhatt

Dharmesh Bhatt

Head - Business Development (India)

Dharmesh's Biography

Read more

Dharmesh Bhatt

Head - Business Development (India)

Dharmesh obtained his master’s degree in chemistry from M.K University and has done an MBA in Industrial Management from National Institute of Management. He has about 27 years of industrial experience during which he has served in many MNCs like Zydus Cadila, Piramal, Dishman Pharma, Daicel etc. He has immense expertise in the purification, isolation & characterization of heterocyclic, macrocyclic, natural products, etc. Dharmesh was also in role of Sales & BD for analytical services, pharma impurity standard, separation services & column business for domestic market.


Connect on linkedin

Dr. Andy Richards

Dr. Andy Richards

Advisory Board Member

Dr. Andy's Biography

Read more

Dr. Andy Richards

Advisory Board Member

Andy Richards is an entrepreneur and investor known for founding and scaling innovative Biotech and Healthtech companies in the UK. He chairs Arecor, Congenica, Abcodia, and Babraham Bioscience Technologies Ltd, and is a director of Ieso Digital Health, Silence Therapeutics plc, Cancer Research Technology, and Sensiia. He advises several investment funds, including Cambridge Innovation Capital and the UCL Technology Fund. Andy, a Cambridge graduate with a PhD in Chemistry, has held positions at ICI (now AstraZeneca) and PA Technology. He has founded and invested in over 25 ventures and received a CBE for services to life-science investment in 2015.

Dr. Rashmi Barbhiya

Dr. Rashmi Barbhaiya

Advisory Board Member

Dr. Rashmi's Biography

Read more

Dr. Rashmi Barbhaiya

Advisory Board Member

Dr. Rashmi Barbhaiya is a seasoned pharmaceutical executive with over 30 years of experience in R&D, encompassing two decades in large pharma and a decade as an entrepreneur. He co-founded and led Advinus Therapeutics and is now advancing a globally networked innovation model to address Pharma R&D challenges. Dr. Barbhaiya holds a Ph.D. in Clinical Pharmacology from the University of London and completed post-doctoral training in the US. He has authored over 150 publications and received numerous awards, including being named an AAPS Fellow and BioSpectrum Entrepreneur of the Year in 2010.

 
 
 
 
 

Connect on linkedin

Simon Stockwell

Simon Stockwell

Senior Scientist II

Simon's Biography

Read more

Simon Stockwell

Senior Scientist II

Simon is a senior cell biologist with over 16 years’ postdoctoral experience working in academic research laboratories. Prior to joining o2h discovery, he contributed to various small molecule drug discovery projects with experience in target validation, screening and hit-to-lead stages. Specializing in high-content image analysis, Simon has supervised screens and developed novel assays for a variety of therapeutic targets in oncology. His postdoctoral career was spent at The Institute of Cancer Research and UCL Institute in London, then more recently with the MRC Cancer Unit in Cambridge.


Connect on linkedin

Rajesh Yeshodharan

Rajesh Yesodharan

Senior Research Scientist - II

Rajesh's Biography

Read more

Rajesh Yesodharan

Senior Research Scientist - II

Rajesh is an invitro biologist with over 17 years of experience in drug discovery research and services in CRO and Pharmaceutical industries. He holds a Master’s degree in Biotechnology and a postgraduate diploma in Regulatory Affairs. He oversaw the high-throughput screening and electrophysiology (Patch clamp) labs at Lupin Ltd. He was instrumental in the development of in vitro biochemical and cell-based assays as well as the screening of small compounds against a variety of targets, including Ion channels, GPCRs, and Enzymes.. Before joining o2h, he worked for Jubilant Biosys Ltd and Lupin Ltd. He was a part of the novel drug discovery programmes at Lupin Ltd., where the two lead molecules have now been out-licenced to AbbVie and Boehringer Ingelheim.


Connect on linkedin

Pragnesh Thakkar

Pragnesh Thakkar

Head - Finance & SCM

Pragnesh's Biography

Read more

Pragnesh Thakkar

Head - Finance & SCM

Mr. Pragnesh Thakkar serves as the Finance Manager of o2h Group for 13+ years. He also heads Accounting, Financials, Secretarial functions of the company. Well versed in Accounting, Financial reporting, MIS and Taxation. He has a degree of Master in Commerce and has total 15 year of industrial work experience.


Connect on linkedin

Bhargavi

Bhargavi Jansari

Senior Manager - Operations

Bhargavi's Biography

Read more

Bhargavi Jansari

Senior Manager - Operations

Bhargavi is an accomplished professional with over a decade of experience in the field of human resource management, holding an MBA in HR. Her expertise encompasses leadership development, shaping organisational culture and values, designing KRAs and performance evaluation systems, talent development and related functions.

 

As a Senior Manager – Operations, she oversees HR, Environmental Health and Safety (EHS), Information and Communication Technology (ICT), and Engineering, providing critical support and guidance in these areas.


Connect on linkedin

Neetu

Neetusingh Sengar

Manager - Human Resource

Neetusingh's Biography

Read more

Neetusingh Sengar

Manager - Human Resource

Neetu is a passionate HR professional with over six years of experience. She has been an integral part of the HR team at the o2h group for a few years now, and she has contributed significantly to various HR functions ranging from talent acquisition to resource planning and forecasting. 

Neetu holds a postgraduate degree in Electronics and Communication from Sardar Patel University and a postgraduate diploma in HRM from Mahatma Gandhi Labour Institute. On days when she is not scouting talent for o2h group, you will find her experimenting with different cuisines in the kitchen, enjoying music and reading books.


Connect on linkedin

Tammy Ward

Head of Design

Tammy's Biography

Read more

Tammy Ward

Head of Design

Tammy is a senior digital creative having 16+ years of experience in designing. She has a passion for producing engaging and effective user experiences and bringing digital marketing campaigns to life.


Connect on linkedin

Ajit Singh Guller

Head - Marketing

Ajit's Biography

Read more

Ajit Singh Guller

Head - Marketing

As the Head of Marketing at the o2h group, Ajit assumes a leadership role, overseeing a team of talented marketing and BD ops professionals dedicated to enhancing the company’s brand presence. Ajit’s responsibilities encompass brand marketing, advertising and research, content and digital marketing, business analytics, as well as public relations and communications.

Before joining the o2h group, Ajit worked with two SME tech companies serving global clients, and a seed stage e-commerce startup. He brings a wealth of experience to the table, with a keen focus on design, user experience, behavior analysis, and digital analytics.


Connect on linkedin

logo-img

o2h discovery private limited.

  • about

    • company overview
    • team
    • culture
    • ESG
  • services

    • Integrated Drug Discovery
    • Fragment-based Drug Discovery
    • Chemistry
    • In-vitro ADME
  • other links

    • news
    • Events
    • o2h community
    • contact
Visit o2h.com o2h discovery
  • social_media_icons
  • social_media_icons
  • social_media_icons
  • social_media_icons

Copyright ©   All rights reserved.

cookies policy privacy policy